Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Abbott India Ltd.

15 May 2025

30685.00

0.41%

Result

Abbott India Ltd - 500488 - Results For The Financial Year Ended March 31, 2025

BSE India

Results for the financial year ended March 31, 2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1680.61	1686.03	1519.78	-0.3%	10.6%
Operating Profit Qtr	428.54	436.09	329.53	-1.7%	30.0%
Net Profit Qtr	367.04	360.78	287.06	1.7%	27.9%
Earning Per Share Adjusted latest Qtr	172.73	169.78	135.09	1.7%	27.9%

* Standalone data

Detailed Results

Abbott India Ltd.

15 May 2025

30685.00

0.41%

Board Meeting

Abbott India Ltd - 500488 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Outcome of Board Meeting

pdf

Biocon Ltd.

15 May 2025

341.60

0.65%

Biocon's businesses at a strong inflection point: MD & CEO Siddharth Mittal

Business Line

Pharma major is preparing to launch its products in several new markets, including Europe, the US, India, and other large emerging markets

Axis Direct decreased Buy price target of Biocon Ltd. to 351.0 on 03 May, 2025.

Alkem Laboratories Ltd.

15 May 2025

5324.00

1.97%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR) With Respect To A Cyber …

BSE India

Enclosed herewith is the disclosure with respect to a cyber security incident involving a US subsidiary of Enzene Biosciences Limited, a subsidiary of the Company.

pdf

Aurobindo Pharma Ltd.

15 May 2025

1205.90

0.39%

Company Update

Aurobindo Pharma Ltd - 524804 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Submission of Annual Secretarial Compliance Report for the Financial Year ended March 31, 2025

pdf

Mankind Pharma Ltd.

15 May 2025

2564.20

-0.33%

Company Update

Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The Securities And Exchange Board …

BSE India

Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015

pdf

Lupin Ltd.

15 May 2025

2029.60

-1.88%

Investor Presentation

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation to be made at the Investors Meet 2025.

pdf

J B Chemicals & Pharmaceuticals Ltd.

15 May 2025

1663.90

1.01%

J B Chemicals & Pharmaceuticals Results Earnings Call for Q4FY25 & Full Year

Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio